@article{b0f15d7ad2bc45389964d84eed90b46f,
title = "Re-treatment of rheumatoid arthritis patients who were initial nonresponders to rituximab: comment on the article by Thurlings et al",
keywords = "Antibodies, Monoclonal/therapeutic use, Antibodies, Monoclonal, Murine-Derived, Antigens, CD19/metabolism, Antirheumatic Agents/therapeutic use, Arthritis, Rheumatoid/drug therapy, B-Lymphocytes/immunology, Blood Sedimentation, C-Reactive Protein/metabolism, Dose-Response Relationship, Drug, Humans, Rituximab, Severity of Illness Index, Treatment Outcome",
author = "Vital, {Edward M} and Shouvik Dass and Buch, {Maya H} and Rawstron, {Andrew C} and Frederique Ponchel and Dennis McGonagle and Paul Emery",
year = "2009",
month = jun,
doi = "10.1002/art.24558",
language = "English",
volume = "60",
pages = "1867",
journal = "Arthritis and Rheumatism",
issn = "0004-3591",
publisher = "John Wiley & Sons Ltd",
number = "6",
}